199 Biotechnologies is a biotech firm that treats a broad range of ailments, from cancer to neurodegenerative diseases.
199 Biotechnologies has raised $7.0M in total funding. The most recent round was Seed. The last funding was announced in September 2024.
199 Biotechnologies is headquartered in England, Germany.
199 Biotechnologies is a biotech firm that treats a broad range of ailments, from cancer to neurodegenerative diseases.
199 Biotechnologies is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"199 Biotechnologies — Funding & Investors." VCBacked, September 27, 2024, https://www.vcbacked.co/company/199-biotechnologies. Accessed August 1, 2026.
VCBacked. (2024). 199 Biotechnologies — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/199-biotechnologies
{{cite web |title=199 Biotechnologies — Funding & Investors |url=https://www.vcbacked.co/company/199-biotechnologies |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated